Cargando…
Examining the Use of Real‐World Evidence in the Regulatory Process
The 21st Century Cures Act passed by the United States Congress mandates the US Food and Drug Administration to develop guidance to evaluate the use of real‐world evidence (RWE) to support the regulatory process. RWE has generated important medical discoveries, especially in areas where traditional...
Autores principales: | Beaulieu‐Jones, Brett K., Finlayson, Samuel G., Yuan, William, Altman, Russ B., Kohane, Isaac S., Prasad, Vinay, Yu, Kun‐Hsing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7093234/ https://www.ncbi.nlm.nih.gov/pubmed/31562770 http://dx.doi.org/10.1002/cpt.1658 |
Ejemplares similares
-
Illustrating potential effects of alternate control populations on real-world evidence-based statistical analyses
por: Huang, Yidi, et al.
Publicado: (2021) -
Large-scale real-world data analysis identifies comorbidity patterns in schizophrenia
por: Lu, Chenyue, et al.
Publicado: (2022) -
Learning Contextual Hierarchical Structure of Medical Concepts with Poincairé Embeddings to Clarify Phenotypes
por: Beaulieu-Jones, Brett K., et al.
Publicado: (2019) -
Temporal bias in case-control design: preventing reliable predictions of the future
por: Yuan, William, et al.
Publicado: (2021) -
Real-world data analyses unveiled the immune-related adverse effects of immune checkpoint inhibitors across cancer types
por: Wang, Feicheng, et al.
Publicado: (2021)